Literature DB >> 9364934

Intratumoral heterogeneity for hsp90beta mRNA levels in a breast cancer cell line.

C Luparello1, A Noël, I Pucci-Minafra.   

Abstract

BC-3A and BC-61 are two breast cancer cell lines that have been cloned from parental 8701-BC cells and exhibit different biosynthetic, proliferative, and invasive properties in vitro. In the attempt to search whether alterations in the profiles of gene expression could be detected, we have submitted both cytotypes to identification of differentially expressed cDNAs. In addition, steroid hormone receptor mRNA arrays and in vivo tumorigenesis of the two lines have been checked. The technique used allowed identification of changes in the expression of the 90-kD heat shock protein-beta (hsp90beta) which is prominently down-regulated in BC-61 cells. Because we have also found that these cells, which lack estrogen receptor mRNA synthesis, display a more invasive behavior in vitro and increased tumorigenesis in vivo, we propose that evaluation of hsp903 transcript levels may be taken into consideration for screening as a novel molecular marker of breast cancer progression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9364934     DOI: 10.1089/dna.1997.16.1231

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  4 in total

1.  The Hsp90 chaperone complex A potential target for cancer therapy?

Authors:  Beatrice D Darimont
Journal:  World J Gastroenterol       Date:  1999-06       Impact factor: 5.742

2.  Genetic prognostic index influences patient outcome for node-positive breast cancer.

Authors:  Shin-Ichi Asaka; Takashi Fujimoto; Junko Akaishi; Kenji Ogawa; Masamitsu Onda
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

Review 3.  Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket.

Authors:  Alison Donnelly; Brian S J Blagg
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

Review 4.  Natural product inhibitors of Hsp90: potential leads for drug discovery.

Authors:  M W Amolins; B S J Blagg
Journal:  Mini Rev Med Chem       Date:  2009-02       Impact factor: 3.862

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.